Foxhall Research Center

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Amgen1 trial
• RAPT Therapeutics, Inc., a member of the GSK plc group of companies1 trial

Closed trials

• Completed

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· Phase 3· Amgen· Source

• Terminated

  An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

  NCT05399368· Phase 2· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Source